US4401764A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immunoassays employing labeled reagent and a conjugate having two binding sites
Assignee: Technicon Instruments Co Ltd
•
Filing: 1981-02-02
•
Granted: 1983-08-30
•
Expires: 2001-02-02
Abstract
Abstract In the immunoassay of antigens in liquids, a reaction mixture is formed containing the liquid under assay, labelled antigen, and a mixed binding reagent which contains an antigen-binding site and a label-binding site, the two sites being spaced apart in the reagent so that a single molecule of labelled antigen cannot bind to both sites. The label is one whose activity is changed upon binding to a label-binding site, and the amount of antigen in the original liquid sample is determined by measuring the activity of the label in the reaction mixture. A preferred label is a fluorophore. The mixed binding reagent preferably consists of two antibodies linked together.
Inventors
- 👤 David S. Smith
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 17:38
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/78; G01N33/53; G01N33/531; G01N33/536; G01N33/542; G01N33/543; G01N33/54306; Y; Y10; Y10S; Y10S436/00; Y10S436/805; Y10S436/815; Y10S436/819; Y10S436/828
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
140 words
A method of immunoassay of an antigen in a liquid sample, which comprises forming a mixture of: (a) sample; (b) a substance bearing a non-radioisotopic label, which substance is the same as the antigen under assay or is so closely similar as to be bindable by an antibody against the antigen; and (c) a mixed binding conjugate which comprises at least one first site selectively bindable to the antigen, and at least one second site selectively bindable to the label, the first and second sites being spaced apart so that a single molecule of labelled substance cannot simultaneously become bound to both a first and a second site, and wherein the activity of the label is changed upon binding to the second site; and detecting the amount of label activity in the mixture and therefrom determining the amount of antigen.
Claim 2
Independent Claim
140 words
A method of immunoassay of an antigen in a liquid sample, which comprises forming a mixture of: (a) sample; (b) a substance bearing a non-radioisotopic label, which substance is the same as the antigen under assay or is so closely similar as to be bindable by an antibody against the antigen; and (c) a mixed binding conjugate which comprises at least one first site selectively bindable to the antigen, and at least one second site selectively bindable to the label, the first and second sites being spaced apart so that a single molecule of labelled substance cannot simultaneously become bound to both a first and a second site, and wherein the activity of the label is changed upon binding to the second site; and detecting the amount of label activity in the mixture and therefrom determining the amount of antigen.
Claim 3
Dependent Claim
20 words
The method of claim 1 wherein the label is a fluorophore or a potential fluorophore, and the activity is fluorescence.
Claim 4
Dependent Claim
34 words
The method of claim 1 wherein component (c) comprises an antibody against the antigen and an antibody against the label, the two antibodies being linked together to form a unitary mixed binding reagent complex.
Claim 5
Dependent Claim
30 words
The method of claim 3 wherein the two antibodies have been raised in the same animal species and are linked together by an antibody to the immunoglobulin of that species.
Claim 6
Dependent Claim
23 words
The method of claim 4 wherein the two antibodies have been raised in rabbits and the linking antibody has been raised in sheep.
Claim 7
Dependent Claim
15 words
The method of claim 3 wherein the two antibodies are linked together by protein A.
Claim 8
Dependent Claim
15 words
The method of claim 3 wherein the two antibodies are linked to a solid substrate.
Claim 9
Dependent Claim
19 words
The method of claim 7 wherein the solid substrate is finely divided solid particles, each particle bearing both antibodies.
Claim 10
Dependent Claim
12 words
The method of claim 8 wherein the solid particles are polyacrylamide beads.
Claim 11
Dependent Claim
18 words
The method of claim 3 wherein the two antibodies are linked together by a bifunctional chemical bridging group.
Claim 12
Dependent Claim
29 words
The method of claim 3 wherein each antibody is conjugated with a hapten, and the bound haptens are cross-linked to form unitary mixed binding reagent complexes containing both antibodies.
Claim 13
Dependent Claim
15 words
The method of claim 11 wherein the haptens are cross-linked by antibodies against the hapten.
Claim 14
Dependent Claim
14 words
The method of claim 1 which is carried out on a discrete manual basis.
Claim 15
Dependent Claim
15 words
The method of claim 1 which is carried out on an automated continuous flow basis.
Claim 16
Dependent Claim
22 words
The method of claim 1 wherein the antigen under assay is gentamicin or another aminoglycoside antibiotic, phenytoin, nortriptyline, or a thyroid hormone.
Claim 17
Dependent Claim
75 words
A specific binding assay method for determining an analyte in a liquid, which method comprises combining said liquid with a non-radioisotopically labeled analyte or analyte analog and a conjugate comprising an analyte binding partner linked with a label binding partner, said binding partners being spaced apart so that a labeled analyte or analyte analog cannot simultaneously bind with the analyte binding partner and the label binding partner; and measuring any resultant change in label signal.
Claim 18
Dependent Claim
75 words
A specific binding assay method for determining an analyte in a liquid, which method comprises combining said liquid with a non-radioisotopically labeled analyte or analyte analog and a conjugate comprising an analyte binding partner linked with a label binding partner, said binding partners being spaced apart so that a labeled analyte or analyte analog cannot simultaneously bind with the analyte binding partner and the label binding partner; and measuring any resultant change in label signal.
Claim 19
Dependent Claim
24 words
The method of claim 16 wherein the analyte binding partner is linked with the label binding partner through at least one protein A molecule.
Claim 20
Dependent Claim
28 words
The method of claim 16 wherein the analyte binding partner and the label binding partner are antibodies and are linked by an antibody to said binding partner antibodies.
Claim 21
Dependent Claim
36 words
The method of claim 16 wherein the analyte binding partner and the label binding partner are each conjugated with an antigen and the antigen of each of said conjugates is bound to a common antibody therefor.
Claim 22
Dependent Claim
21 words
The method of claim 16 wherein the analyte binding partner and the label binding partner are linked to a solid substrate.
Claim 23
Dependent Claim
32 words
The method of claim 20 wherein the solid substrate is comprised of polyacrylamide beads having a specific gravity of about one and a refractive index which is close to that of water.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-08-29 | 1987-02-28 | 1987-08-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-08-29 | 1991-02-28 | 1991-08-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-08-29 | 1995-02-28 | 1995-08-30 | $7700.00 | Window Closed / Lapsed |